These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Technology, medicine & health, Part 3. Therapeutics for tomorrow. Davidson SN Healthc Forum J; 1995; 38(1):52-60. PubMed ID: 10154288 [No Abstract] [Full Text] [Related]
5. Engineered riboswitches as novel tools in molecular biology. Bauer G; Suess B J Biotechnol; 2006 Jun; 124(1):4-11. PubMed ID: 16442180 [TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides as therapeutics for malignant diseases. Ho PT; Parkinson DR Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689 [TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides in the design of new therapeutic strategies. Piulats J; Tarrasón G Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():31-2. PubMed ID: 9403853 [No Abstract] [Full Text] [Related]
9. Antisense oligonucleotide technology in the development of cancer therapeutics. Tseng BY; Brown KD Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240 [No Abstract] [Full Text] [Related]
12. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method. Yildiz D; Oztas H; Hilal Ates B Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566 [TBL] [Abstract][Full Text] [Related]
13. Application of antisense oligonucleotides for gene functionalization and target validation. Bennett CF; Cowsert LM Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy in hematology. Benz EJ; Bank A Rev Invest Clin; 1994 Apr; Suppl():143-6. PubMed ID: 7886298 [No Abstract] [Full Text] [Related]
15. Antisense oligonucleotide technology: from EST to therapeutics. Giles RV Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617 [TBL] [Abstract][Full Text] [Related]
16. Antisense molecules for targeted cancer therapy. Wacheck V; Zangemeister-Wittke U Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913 [TBL] [Abstract][Full Text] [Related]